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A best evidence topic in vascular surgery was written according to a structured protocol. The question
addressed was: In patients undergoing haemodialysis with thrombosed autogenous arteriovenous
ﬁstulae, does surgical management as compared to endovascular management improve clinical
outcomes?
A total of 130 papers were identiﬁed using the search protocol described, of which four represented
the best evidence available to answer the clinical question. The authors, journal, date and country of
publication, patient group studied, study type, relevant outcomes and results of these papers are
tabulated.
Three of the four studies demonstrated no signiﬁcant difference between the initial success rates of
surgical or endovascular management. However, one study illustrated that hybrid surgery (a combina-
tion of endovascular and surgical techniques) signiﬁcantly improved initial success rates, shortened
hospital stays and decreased total monetary costs. Furthermore, three studies showed that subsequent
ﬁstula patency rates were signiﬁcantly higher when surgical management was instigated. Nevertheless,
one study suggested that surgery worsened subsequent patency rates and that in fact surgical patients
were more likely to require temporary dialysis catheters than endovascular patients.
Therefore, the clinical bottom line is that with careful patient and ﬁstula selection, surgery provides a
number of beneﬁts over endovascular management of thrombosed autogenous arteriovenous ﬁstulae,
particularly in the medium to long term. However, further appropriately powered and randomised Level
1 studies are necessary to clarifying this important issue.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence topic was constructed according to a structured
protocol, as described in the International Journal of Surgery [1].2. Clinical scenario
You create an autogenous arteriovenous ﬁstula (AVF) to facili-
tate haemodialysis in a patient with end-stage renal failure. Un-
fortunately, four months later, the dialysis nurse has difﬁculty
cannulating the ﬁstula and you suspect thrombosis. This is later
conﬁrmed by ultrasound. A colleague suggests reoperation to
remove the thrombus and restore patency, whilst another suggests: þ44 1273644440.
.G. Klimach), J.Norris1@uni.
ciates Ltd. Published by Elsevier Ltan endovascular intervention. You are unsure which approach
would provide the optimum clinical outcomes and so resolve to
consult the literature.3. Three-part question
In [patients undergoing haemodialysis, with thrombosed
autogenous AVF], does [surgical management (SM)] as compared to
[endovascular management (EVM) improve clinical outcomes]?4. Search strategy
A search strategy using Medline was from 1950 to May 2013
using the PubMed interface: (arteriovenous ﬁstula OR AVF) AND
dialysis AND thromb* AND (treatment OR management).ti,ab. The
search was duplicate ﬁltered. Reference lists of key articles were
also searched for additional references.d. All rights reserved.
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A total of 130 papers were identiﬁed using the reported PubMed
search. Of these 21 were retrospective observational studies which
mentioned AVF failure but did not directly address the research
questions 58 were completely unrelated, a further 15 were review
articles on loosely related topics 12 were solely concerned with
drug treatment for the management of failed AVF, 11 were unre-
lated case reports, 7 were solely concerned with technical aspects
of the surgery 5 were prospective observational studies of AVF
failure, 4 were duplications, 2 were unrelated case series, and 2
were basic science articles. Included studies discussed the use of
surgical, interventional radiological and hybrid techniques. Four
articles represented the best evidence to answer the clinical
question. These articles were selected and are presented in Table 1.
6. Results
End-stage renal failure is an increasing healthcare burden.
Autogenous AVF remain the preferred route for haemodialysis ac-
cess due to superior patency and fewer complications. However,
ﬁstula thrombosis remains an on-going threat that must be
managed appropriately to preserve remaining access options for as
long as possible. Thrombosed AVFs can bemanaged surgically (SM).
In SM a ﬁstulotomy is performed and thrombus removed using
ﬁngers and heperaised saline irrigation. Alternatively thrombosed
AVFs can be managed using less invasive endovascular techniques
(EVM). EVM involves penetrating thrombosed AVFs with fogarty
balloon catheters, with our without, radiological guidance and
using a combination of mechanical and pharmacological throm-
bolytic agents to restore patency. There is limited evidence in the
current literature to demonstrate whether surgical or endovascular
techniques offer better clinical outcomes.
Tordior et al. [2] performed a systematic review of the literature
regarding the management of thrombosed autogenous and graft
AVF. Measured outcomes were initial success rates, one year
patency rates (primary) and secondary patency rates. Large
population-based, randomised and meta-analyses were eligible for
inclusion, whilst small patient studies, case reports and non-
English language studies were excluded. The authors did not state
their initial potential results size, but eventually 78 papers were
used, of which only 36 pertained to the SM (n ¼ 6) and EVM
(n ¼ 30) of autogenous AVF. SM predominantly consisted of
thrombectomy with or without proximal reanastomosis. EVM
mainly referred to mechanical thrombectomy or thromboaspira-
tion with or without urokinase. Across these trials, initial success
rates were similar for SM as for EVM (90% versus 89%). Overall
however, one year patency rates (primary) were greater for SM
than for EVM (74% versus 40%). Again across the studies, secondary
patency rates were higher for SM compared with EVM (87% versus
72%). This systematic review is limited by only including non-
randomised studies of thrombosed autogenous AVF, including a
relatively small number of studies examining SM, including very
few comparative studies and by excluding non-English language
studies. Lack of quality of the original studies and the heterogeneity
that existed between these studies subsequently reduced the value
of this systematic review, preventing the authors from pooling the
data on for meta-analysis.
Kim et al. [3] undertook a retrospective cohort study of 117
haemodialysis patients with thrombosed autogenous AVF who
were treated with SM (n¼ 87) or EVM (n¼ 30). Outcome measures
were initial success rates, ﬁve year patency rates (post-interven-
tional), temporary dialysis catheter requirement and major
complication rates. Initial success rates were high for both SM and
EVM (98.9% versus 96.7%). Five year patency rates (post-interventional) were worse with SM compared to EVM (89.9%
versus 96.7%). Temporary dialysis catheters were required more
frequently with SM thanwith EVM (27.6% versus 0%, p < 0.001). No
major complications occurred in any of the patients studied (0%
versus 0%). Despite being well conducted generally, there were
methodological ﬂaws with this paper. Utilising ‘surgeon choice’
over treatment randomisation, disparity in treatment group sizes,
small numbers of patients undergoing EVM and biased selection
criteria, distributing potentially less serious thromboses to the EVM
group, may all contribute to undermining the value of this study.
Furthermore, the authors including a heterogeneous group of
procedures including proximal neoanastomosis, replacement of the
stenosed segment with a polytetraﬂuoroethylene graft and patch
angioplasty, under the category of SM, perhaps reducing the
generalizability of this study when considering the SM of other
centres.
Hyun et al. [4] performed a retrospective cohort study of 59
haemodialysis patients with thrombosed autogenous AVF that
underwent hybrid SM (primarily SM employing intra-operative use
of EVM techniques to enhance thrombus clearance, n ¼ 40) or EVM
(n ¼ 19). Outcome measures were initial success rates, and six
month,12 month and 24month patency rates (primary), procedure
time, mean hospital stay length, complication rates, supply costs
and total costs. Initial success rates were signiﬁcantly better with
SM than with EVM (92.5% versus 68.4%, p ¼ 0.005). Six month, 12
month and 24 month patency rates (primary) were signiﬁcantly
longer in SM as compared with EVM (85.9% versus 36.8%, 81.1%
versus 26.3% and 81.1% versus 21.1%, respectively, p < 0.001). Pro-
cedure times, in minutes, were not signiﬁcantly different between
SM and EVM (108.1  47.9 vs. 115.6  63.5, p ¼ 0.624). Mean hos-
pital stay, in days, was shorter with SM compared with EVM, but
not signiﬁcantly so (1 2 versus 2.3 2.9, p¼ 0.058). Complication
rates were similar between SM and EVM (17.5% versus 15.8%,
p ¼ 0.870). There was no signiﬁcant difference in supply costs, in
Korean won, between SM and EVM (3.75  105 versus 5.71  105,
p ¼ 0.065). However, total costs, in Korean won, were signiﬁcantly
less with SM than EVM (1.56  106 versus 2.03  106, p ¼ 0.019).
This was a well conducted study that was limited by a relatively
small sample size and lack of randomisation. The employment of
hybrid surgical techniques, as opposed to a simple surgical
approach, heavily limits the comparability of this study. Firstly, no
other research group took this unique approach and so this makes it
difﬁcult to contrast outcomes. Secondly, the nature of the authors’
hybrid approach implies that not every patient in their hybrid arm
received consistent management; one sub-group of patients
(n ¼ 11) received additional surgical angioplasty, whilst the others
(n ¼ 29) did not, thus reducing the value of their conclusions.
Morosetti et al. [5] conducted a retrospective cohort study of
475 haemodialysis patients with autogenous AVF; 54 suffered
thrombosis and had SM (n ¼ 26) or EVM (n ¼ 28). Measured out-
comes were initial success rates and six month patency rates. There
was no signiﬁcant difference in initial success rates between SM
and EVM (74% versus 74.5%). However, six month patency was
greater with SM compared with EVM (88.5% versus 73.5%).
Although the authors had a large patient group, their absolute
numbers of thromboses were low, thereby limiting the value of
their study. Additional drawbacks included the non-randomised,
retrospective nature of the study. Interestingly, when considering
AVF separately by anatomical location, the authors found that SM
was preferable for distal AVF, whereas EVM was preferable for
proximal AVF.
The consensus of the best available evidence suggests that the
current decision to opt for surgical or endovascular management
depends largely on centre preference. Most studies demonstrated
no signiﬁcant difference between the initial success rates of
Table 1
Best evidence papers.
Author, date and country, study
type (level of evidence)
Patient group Outcomes Key result Comments
Tordior et al. [2] 2009
J. Vasc. Surg.
The Netherlands
Systematic review of
non-randomised trials
(Level 3 evidence)
36 studies investigating
haemodialysis
patients with autogenous AVF
undergoing
SM or EVM
SM n ¼ 6
EVM n ¼ 30
Initial success rates (SM vs. EVM) 90% vs. 89% No signiﬁcant differences were found between the
initial success rates of both SM and EVM. However,
both one year patency rates (primary) and
secondary patency rates were greater with
SM. Limitations were the inclusion of only
non-randomised studies and very small numbers
of SM papers. Trials included were heterogeneous
and of low quality and so could not be meta-analysed.
One year patency rates (primary) (SM vs. EVM) 74% vs. 40%
Secondary patency rates (SM vs. EVM) 87% vs. 72%
Kim et al. [3] 2011
Ther. Apher. Dial. Korea
Retrospective cohort study
(Level 3 evidence)
117 haemodialysis patients with
autogenous AVF undergoing SM
or EVM
SM n ¼ 87
EVM n ¼ 30
Initial success rates (SM vs. EVM) 98.9% vs. 96.7% No signiﬁcant difference existed between success
rates or major complication rates of SM and EVM.
Five year patency rates (post-interventional) and
temporary dialysis catheter requirements were
both worse with SM. Methodological ﬂaws
included non-random treatment allocation and
heterogeneous approaches to SM.
Five year patency rates (post-interventional)
(SM vs. EVM)
89.9% vs. 96.7%
Temporary dialysis catheter requirement
(SM vs. EVM)
27.6% vs. 0%, p < 0.001
Major complication rates (SM vs. EVM) 0% vs. 0%
Hyun et al. [4] 2011
J. Korean Surg. Soc. Korea
Retrospective cohort study
(Level 4 evidence)
59 haemodialysis patients with
autogenous AVF undergoing hybrid
SM or EVM
SM n ¼ 40
EVM n ¼ 19
Initial success rates (SM vs. EVM)
Six month patency rates (primary) (SM vs. EVM)
12 month patency rates (primary) (SM vs. EVM)
24 month patency rates (primary) (SM vs. EVM)
Procedure time (minutes) (SM vs. EVM)
Mean hospital stay length (days) (SM vs. EVM)
Complication rates (SM vs. EVM)
Supply costs (Korean won) (SM vs. EVM)
Total costs (Korean won) (SM vs. EVM)
92.5% vs. 68.4%, p ¼ 0.005
85.9% vs. 36.8%, p < 0.001
81.1% vs. 26.3%, p < 0.001
81.1% vs. 21.1%, p < 0.001
108.1  47.9 vs. 115.6  63.5,
p ¼ 0.624
1  2 vs. 2.3  2.9, p ¼ 0.058
17.5% vs. 15.8%, p ¼ 0.870
3.75  105 vs. 5.71  105, p ¼ 0.065
1.56  106 vs. 2.03  106, p ¼ 0.019
Initial success rates, and six month, 12 month and
24 month patency rates (primary), and total costs
were all signiﬁcantly better with SM. Mean hospital
stay length was shorter with SM. No signiﬁcant
difference was apparent between procedures times,
complication rates or supply costs between SM and
EVM. The study confounded by small sample size,
non-randomisation and reliance on ‘hybrid’ SM.
Morosetti et al. [5] 2002
J. Vasc. Access. Italy
Retrospective cohort study
(Level 3 evidence)
54 thromboses in 475 haemodialysis
patients with autogenous AVF
undergoing SM or EVM
SM n ¼ 26
EVM n ¼ 28
Initial success rates (SM vs. EVM) 74% vs. 74.5% No signiﬁcant differences in the initial success rates
of SM or EVM were shown. Six month patency was
greater for SM. Drawbacks included a low number
of thromboses, non-random treatment allocation
and retrospective data collection.
Six month patency rates (SM vs. EVM) 88.5% vs. 73.5%
AVF ¼ arteriovenous ﬁstula, EVM ¼ endovascular management, SM ¼ surgical management.
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BEST EVIDENCE TOPICsurgical or endovascular management. However, one trial showed
that hybrid surgery signiﬁcantly elevated initial success rates,
decreased hospital stays and reduced total monetary costs; perhaps
indicating hybrid surgery as an avenue for further research. Addi-
tionally, the majority of papers showed that subsequent ﬁstula
patency rates were signiﬁcantly higher with surgical management.
Nevertheless, one study suggested that surgery worsened subse-
quent patency rates and that in fact surgical patients were more
likely to require temporary dialysis catheters than endovascular
patients.
7. Clinical bottom line
With careful patient and ﬁstula selection, surgery provides a
number of beneﬁts over endovascular management of throm-
bosed autogenous arteriovenous ﬁstulae, particularly in the me-
dium to long term. However, in this era of evidence-based
medicine it is essential that appropriately powered, prospective
and randomised Level 1 studies are performed to clarify this
important issue.
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